The Company is a Korea-based company mainly engaged in the research and development of cancer therapeutic vaccine. The Company develops cancer therapeutic vaccine through development and clinical research of BVAC pipeline products using CeliVax original technology. The Company was established on December 01, 2006. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 20, 2019.
Headquarters
5F, 142-Dong, College Of Pharmacy, Seoul Univ., 1, Gwanak-Ro, Gwanak-Gu
Seoul; Seoul;
Contact Details: Purchase the Cellid Co.,Ltd. report to view the information.
Website: http://www.cellid.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service